Price of key diabetes drug may crash as Novartis risks losing patent
A look at the top 10 brands of Novartis in India shows that mature brands like Voveran and Calcium Sandoz are clocking low single-digit growth08-10-2019
08-10-2019
NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dear Sirs, Please note that in terms of the applicable provisions of the SEBI Listing Regulations, the Company has received intimation regarding loss of share certificate from the following shareholder details of which are mentioned in the letter. The Registrar and Share Transfer Agent of the Company i.e. Link Intime India Private Limited has received a request letter from the abovementioned shareholder and have informed the Company about the same on September 27, 2019 and September 29, 2019, respectively. Further, subject to completion of required formalities by the shareholder, the Company will issue duplicate share certificate in lieu thereof.30-09-2019
NOVARTIS INDIA LTD. - 500672 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Intimation of Newspaper advertisement by Novartis India Limited ('the Company') regarding the Meeting of the Board of Directors of the Company for the quarter and half year ending on September 30, 2019. Apropos the subject matter quoted above, please find enclosed herewith the copies of the newspaper Notices in 'Financial Express' and 'Navshakti' on September 21, 2019. This is for your information and record. Thanking You23-09-2019
NOVARTIS INDIA LTD. - 500672 - Closure of Trading Window
Dear Sir/ Madam, Please be informed that the meeting of the Board of Directors of the Company is scheduled to be held on Friday, November 8, 2019, to inter alia consider the unaudited financial results of the Company for the quarter and half year ending on September 30, 2019 ("said results"). In this connection, further note that pursuant to the Company''s Code of Conduct to regulate, monitor and report share trading by Insiders ["the Code"], the trading window for dealing in securities of the Company shall remain closed from Tuesday, October 1, 2019 to Sunday, November 10, 2019 (both days inclusive). The same is being duly communicated to all the Designated Persons under the Code which is available on the Company''s website i.e. www.novartis.in. This is for your information.20-09-2019
NOVARTIS INDIA LTD. - 500672 - Board Meeting Intimation for Intimating The Stock Exchange That The Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On Friday, November 8, 2019.
NOVARTIS INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2019 ,inter alia, to consider and approve the unaudited financial results of the Company for the quarter and half year ending on September 30, 2019 ("said results").20-09-2019
Novartis India Ltd - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dear Sirs, Please note that in terms of the applicable provisions of the SEBI Listing Regulations, the Company has received intimation regarding loss of share certificate from the following shareholder: Stop transfer date: August 22, 2019 Folio No. S000381; 02325977 Name of the shareholder: Santosh Agarwal Certificate No. 435752; 23944 Distinctive No. 31919942 - 31919951; 16106619 - 16106708 No. of shares 10, 90 Reason - Lost by holder The Registrar and Share Transfer Agent of the Company i.e. Link lntime India Private Limited has received a request letter from the abovementioned shareholder and have informed the Company about the same on Friday, August 23, 2019. Further, subject to completion of required formalities by the shareholder, the Company will issue duplicate share certificate in lieu thereof. Thanking you26-08-2019
Novartis India Ltd - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dear Sirs, Please note that in terms of the applicable provisions of the SEBI Listing Regulations, the Company has received intimation regarding loss of share certificate from the following shareholder: Stop transfer date: August 20, 2019 Folio No. 02023261 Name : Abhay Nath Thakur Certificate No. 9302 Distinctive No. 3615087 - 3615106 No. of Shares - 20 Reason - Lost by holder The Registrar and Share Transfer Agent of the Company i.e. Link lntime India Private Limited has received a request letter from the abovementioned shareholder and have informed the Company about the same today i.e. on August 21, 2019. Further, subject to completion of required formalities by the shareholder, the Company will issue duplicate share certificate in lieu thereof. Thanking you.21-08-2019
NOVARTIS INDIA LTD. - 500672 - Reg. 34 (1) Annual Report
Dear Sir/ Madam, The 71st Annual General Meeting of the Company was held on Friday, August 9, 2019 at 11:30 a.m. at Mumbai Cricket Association [MCA] Banquet Hall, Ground Floor, G Block BKC, RG - 2, Bandra (E), Mumbai 400 051 ('said AGM'). In this regard, please find enclosed the Annual Report of the Company for the Financial Year 2018-19 alongwith the Notice of the said AGM duly considered and adopted by the Members of the Company. This is for your information and record. Thanking you19-08-2019
Here's why Novartis CEO thinks FDA process could have been handled better
Novartis has said that it learned of the data manipulation on March 14 and alerted the US Food and Drug Administration17-08-2019
Top-level exits in pharma MNCs: Quirk of timing or changes take their toll?
In June, Novartis (in India) appointed Sanjay Murdeshwar as Vice-Chairman and Managing Director, following the exit of Milan Paleja15-08-2019